GB-CHC-1099776-2WMalaria ConsortiumMalaria Consortium is assessing the feasibility, coverage, health impact and cost-effectiveness of a hybrid delivery model for malaria vaccines in Kebbi state, Nigeria, in collaboration with federal and state health authorities, including the National Primary Health Care Development Agency and the National Malaria Elimination Programme. This implementation research study is designed to identify the most effective strategies for maximising the health impact of malaria vaccines in areas of highly seasonal transmission through improved coverage.GAVI, The Vaccine AllianceMalaria ConsortiumMalaria Consortiumiati@malariaconsortium.orgThe Green House, 244-254 Cambridge Heath Road, London, E2 9DA, United KingdomMalaria control336743GB-CHC-1099776-2W-NGMalaria ConsortiumMalaria Consortium is assessing the feasibility, coverage, health impact and cost-effectiveness of a hybrid delivery model for malaria vaccines in Kebbi state, Nigeria, in collaboration with federal and state health authorities, including the National Primary Health Care Development Agency and the National Malaria Elimination Programme. This implementation research study is designed to identify the most effective strategies for maximising the health impact of malaria vaccines in areas of highly seasonal transmission through improved coverage. [Nigeria]Malaria ConsortiumMalaria ConsortiumMalaria Consortiumiati@malariaconsortium.orgThe Green House, 244-254 Cambridge Heath Road, London, E2 9DA, United KingdomMalaria control381745951563270